CELG News Alert Celgene Corp (CELG) 113.52 01/03/2015 13:32:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 113.52 $CELG

How These 3 Stocks Doubled Investors' Money in Q4
Todd Campbell, The Motley Fool - Motley Fool - Sat Jan 03, 9:31AM CST
Source: Flickr user  Tax Credits Most of the time, life-changing financial gains are generated over the long haul, not in the blink of an eye. However, sometimes stocks can put up jaw-dropping returns over a short period of time too. For example,...
BLUE: 91.26 (-0.46), ISIS: 61.57 (-0.17), ALNY: 97.77 (+0.77), OVAS: 45.83 (+1.61), GILD: 94.91 (+0.65), RGLS: 17.19 (+1.15), CELG: 113.52 (+1.66)

Final Glance: Biotechnology companies
AP - Fri Jan 02, 5:52PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
GILD: 94.91 (+0.65), AMGN: 159.89 (+0.60), CELG: 113.52 (+1.66)

Cellectis Is Late To The CAR-T Cell Race, But Could Finish First
Intrepid Investor - at Seeking Alpha - Fri Jan 02, 3:21PM CST

BLUE: 91.26 (-0.46), BLCM: 22.86 (-0.18), KITE: 60.61 (+2.94), JUNO: 48.25 (-3.97), GSK: 42.37 (-0.37), NVS: 92.25 (-0.41), CELG: 113.52 (+1.66)

An Investor's Guide: Market-Leading Industries In 2014
at Investor's Business Daily - Fri Jan 02, 1:57PM CST
At this time a year ago, the world was gearing up for the Winter Olympics in Sochi, Russia. Few things put in perspective the contrast experienced by global markets in 2014 like the vast squandering of political capital that followed the Sochi Games...
SPLS: 17.61 (-0.51), PTRY: 36.60 (-0.46), MNK: 96.96 (-2.07), BIIB: 342.01 (+2.56), ACT: 259.13 (+1.72), EA: 46.87 (-0.14), HA: 25.27 (-0.78), PANW: 121.42 (-1.15), LUV: 42.69 (+0.37), CELG: 113.52 (+1.66), AGN: 212.75 (+0.16), TTWO: 28.09 (+0.06), VDSI: 27.30 (-0.91), VA: 43.81 (+0.56), AAL: 53.91 (+0.28), ODP: 8.43 (-0.14)

Midday Glance: Biotechnology companies
AP - Fri Jan 02, 12:20PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
GILD: 94.91 (+0.65), AMGN: 159.89 (+0.60), CELG: 113.52 (+1.66)

Stocks Reverse Lower; Apple Plunges Below Support
at Investor's Business Daily - Fri Jan 02, 10:59AM CST
Stocks were lower midday Friday after turning tail in the first session of 2015. The Nasdaq fell 0.7%, the S&P 500 lost 0.3% and the Dow Jones industrial average slipped 0.1%. Volume was tracking well above Wednesday's levels in the stock market...
BIIB: 342.01 (+2.56), ACT: 259.13 (+1.72), IBM: 162.06 (+1.62), ALXN: 186.60 (+1.57), MSFT: 46.76 (+0.31), LOCK: 15.89 (-2.62), AAPL: 109.33 (-1.05), CELG: 113.52 (+1.66)

Individual Investor Portfolio: Solid Results, But Energy Sell-Off And Biotechnology Add Volatility
James Sands - at Seeking Alpha - Fri Jan 02, 9:45AM CST

KMI: 42.81 (+0.50), BIIB: 342.01 (+2.56), ANET: 62.68 (+1.92), PCYC: 124.46 (+2.20), MKC: 73.95 (-0.35), HSY: 103.71 (-0.22), JBHT: 83.21 (-1.04), SFM: 34.02 (+0.04), GWW: 255.22 (+0.33), GOOG: 524.81 (-1.59), PCP: 238.44 (-2.44), SNI: 75.94 (+0.67), UPS: 110.38 (-0.79), PEP: 94.44 (-0.12), T: 33.87 (+0.28), CMI: 146.42 (+2.25), AAPL: 109.33 (-1.05), UNP: 118.61 (-0.52), PSX: 72.29 (+0.59), NSC: 109.15 (-0.46), FB: 78.45 (+0.43), VFC: 73.76 (-1.14), DISCA: 34.48 (+0.03), COP: 68.92 (-0.14), WFC: 54.70 (-0.12), TSN: 39.95 (-0.14), CELG: 113.52 (+1.66), WWAV: 34.76 (-0.23), PXD: 149.89 (+1.04), GILD: 94.91 (+0.65), PG: 90.44 (-0.65)

Early Glance: Biotechnology companies
AP - Fri Jan 02, 9:21AM CST
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
GILD: 94.91 (+0.65), AMGN: 159.89 (+0.60), CELG: 113.52 (+1.66)

Celgene (CELG) Breaks Through Resistance at $113.94
Comtex SmarTrend(R) - Fri Jan 02, 8:58AM CST
Celgene (NASDAQ:CELG) has opened bullishly above the pivot of $112.73 today and has reached the first level of resistance at $113.94. Investors may be interested in a cross of the next upside pivot targets of $116.03 and $119.33.
CELG: 113.52 (+1.66)

5 Biotech Stocks With Big News Due In January
at Investor's Business Daily - Wed Dec 31, 12:15PM CST
The biotech industry is set to hit the ground running in 2015, with January alone bringing a passel of potentially stock-moving events by some of the biggest players. The second full week of the month will bring the annual JPMorgan Healthcare...
BIIB: 342.01 (+2.56), ESRX: 84.65 (-0.02), VRTX: 123.07 (+4.27), GILD: 94.91 (+0.65), ABBV: 65.89 (+0.45), BMY: 59.51 (+0.48), CELG: 113.52 (+1.66)

These 3 Biotechs Are Looking at a Happy New Year
Todd Campbell, The Motley Fool - Motley Fool - Wed Dec 31, 11:33AM CST
This healthcare edition of Industry Focus takes a look at three biotech stocks and why each company is positioned for a great performance in the coming year. If your portfolio could use some exposure to healthcare and biotechs, join the Fool's...
NFLX: 348.94 (+7.33), MDVN: 101.79 (+2.18), JNJ: 104.52 (-0.05), AMZN: 308.52 (-1.83), JPM: 62.49 (-0.09), GILD: 94.91 (+0.65), AGIO: 109.76 (-2.28), AAPL: 109.33 (-1.05), XLRN: 38.26 (-0.70), CELG: 113.52 (+1.66)

Jim Cramer's 'Mad Money' Recap: How to Become an Even Better Investor
at The Street - Tue Dec 30, 6:00PM CST
Cramer's first rule: Diversification is the only way to invest.
DUK: 84.05 (+0.51), SVU: 9.65 (-0.05), FB: 78.45 (+0.43), SKT: 37.45 (+0.49), ED: 66.34 (+0.33), FRT: 135.74 (+2.28), RSH: 0.39 (+0.02), PLKI: 55.72 (-0.55), CELG: 113.52 (+1.66), RAD: 7.63 (+0.11), T: 33.87 (+0.28), S: 4.24 (+0.09), CMG: 678.40 (-6.11), GLD: 114.08 (+0.50), GOOGL: 529.55 (-1.11), VZ: 46.96 (+0.18), AAPL: 109.33 (-1.05), REGN: 410.16 (-0.09)

Will Biotech Fire On All Cylinders In 2015?
Life Sciences Report - at Seeking Alpha - Tue Dec 30, 3:15PM CST
Making predictions for the New Year may feel as productive as peering into a crystal ball. But in the life sciences, hard science and long experience back prognostication. The biotech market enjoyed a stellar 2013 and withstood a solid check in early...
MDT: 71.88 (-0.32), PFE: 31.33 (+0.18), CLDX: 18.41 (+0.16), COV: 102.07 (-0.21), INCY: 73.76 (+0.65), NBS: 3.73 (-0.04), BMY: 59.51 (+0.48), OMER: 25.01 (+0.23), CELG: 113.52 (+1.66), ISIS: 61.57 (-0.17), GILD: 94.91 (+0.65), NVAX: 5.76 (-0.17), AZN: 70.40 (+0.02), CEMP: 22.89 (-0.62), FPRX: 27.71 (+0.71)

Start the New Year Off Right With the 3 Best Biotech Stocks
Motley Fool Staff - Motley Fool - Tue Dec 30, 6:43AM CST
Source: Flickr user  dpotera . While many are popping champagne corks to welcome in the new year, we know that many fellow Fools (probably too many of us) will be wondering which companies could be the best bets for our portfolios in 2015. To help...
GILD: 94.91 (+0.65), ABBV: 65.89 (+0.45), CELG: 113.52 (+1.66)

DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially
SA Editors - Seeking Alpha - Tue Dec 30, 6:05AM CST
Today we present the fifth piece in Seeking Alpha's Positioning for 2015 series. This year we have once again asked experts on a range of different asset classes and investing strategies to offer their vision for the coming year and beyond....
BIIB: 342.01 (+2.56), SPY: 205.43 (-0.11), PTLA: 28.51 (+0.19), PCYC: 124.46 (+2.20), GILD: 94.91 (+0.65), ACHN: 13.33 (+1.08), MRK: 57.19 (+0.40), EW: 127.72 (+0.34), IBB: 306.34 (+2.99), HQH: 31.87 (+0.38), REGN: 410.16 (-0.09), CELG: 113.52 (+1.66)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

College Towns Spark Entrepreneurial Booms Across US

Updated Category News Views 45

Entrepreneurial Sparks Fly in Unlikely Places Turns out, it's not just the Silicon Valleys of the world creating startups—sometimes it's the coffee-driven college town where innovation quietly roots itself. GoDaddy's inaugural list of America's Most Entrepreneurial College Towns decimates the old idea that only big cities can be entrepreneurial havens. Instead, eight...

Continue Reading
BAILOR Welcomes Co-Founder Bob Bailor to Coach Academy

Updated Category News Views 58

A New Chapter for a Seasoned Entrepreneur There's a certain irony in a seasoned business vet stepping into a new role at his own daughter's company, and that's exactly what's unfolding with the Bailors. Huntsville's own BAILOR isn't just another growth strategy company; it's the embodiment of a father-daughter dream team. After years as the ordinary head honcho, Bob...

Continue Reading
Investigations Target PAG, BRBS, PSNL for Fair Shareholder Deals

Updated Category News Views 9

Unpacking the Shareholder's Dilemma in Major Transactions Alright, folks, let's dig into this mess with our favorite Wall Street magnifying glass. We've got Penske Automotive Group (NYSE: PAG), Blue Ridge Bankshares (NYSE: BRBS), and Personalis, Inc. (NASDAQ: PSNL) under the spotlight, each locking themselves into deals that might not exactly scream 'fair play' for the...

Continue Reading
Beta Bionics Faces Class Action Deadline Amid Controversy

Updated Category News Views 16

Beta Bionics' Investors in a Bind: Lead Plaintiff Opportunity Looms Alright, folks, it’s time to size up the situation at Beta Bionics, Inc. (NASDAQ: BBNX). If you're holding onto their stock and nursing some serious losses, you're not alone. The clock's ticking on the November 3, 2026 deadline to step up and lead the charge in a class action lawsuit. What's the Fuss...

Continue Reading
Cork's Market Power Surges in U.S. Wine Industry

Updated Category News Views 43

Cork: The Unsung Hero of the Wine Bottle You'd think a simple piece of bark couldn't shift the billion-dollar wine industry, but cork closures are doing just that. According to new NielsenIQ data, these natural stoppers are holding their ground as top dogs in the U.S. wine market. Who would've guessed that cork would drive the highest off-premise revenue? That's some...

Continue Reading
JAS Hits Top 1% in EcoVadis Sustainability Rankings

Updated Category News Views 101

A Platinum Performance in EcoVadis Ratings JAS Worldwide, hustling around in the logistics and supply chain sector, just nailed a spot in the much-coveted top 1% bracket for sustainability according to EcoVadis. We’re talking about a company that’s not only steering the mammoth ships of logistics but now it’s also wearing sustainability like a crown. This...

Continue Reading
Navigating Holiday Eating with GLP-1 Support

Updated Category News Views 21

GLP-1 Programs: A New Holiday Challenge As if the holidays weren't already a puzzle with family dinners and over-the-top office parties, folks on a GLP-1 program have another set of questions, like navigating a buffet without guilt. Ain’t no sugarcoating it—December throws every routine straight out the window. It's not just about what pie to eat, but how to keep your...

Continue Reading
CashorTrade and Front Gate Unite for Ticket Resale

Updated Category News Views 7

Big News for Festival Enthusiasts Imagine the scene: you've snagged tickets to the hottest festival of the year—maybe Lollapalooza or Austin City Limits—but life throws a curveball, and you can't go. That's where CashorTrade and Front Gate Tickets come in, forming a dynamic duo for festival-goers who need to swap tickets at face value. It’s like a lifeline for every...

Continue Reading
Neuberger Fund Ups Distribution Amid Market Challenges

Updated Category News Views 0

Neuberger Boosts Distribution: What's Driving This? I ain't about to sugarcoat it: the Neuberger Next Generation Connectivity Fund (NYSE: NBXG) decided to jack up its monthly distribution rate to $0.132 per share. This announcement, hitting wallets on November 30, 2026, has a record and ex-date of November 16. Now, that's a good ol' reliable payout for folks holding NBXG...

Continue Reading
KickHouse Partners with Sam Alvey for Glove Line Launch

Updated Category News Views 14

KickHouse Pounces with New Fighter Partnership Looks like KickHouse isn't playing games, folks. They've teamed up with fighter Sam Alvey to launch a new boxing glove line. You got your Warbird, your Desert Ghost, and your Night Ops gloves—names straight out of a war zone. These 16-ounce hammers are out now, and they kickstart a broader gear lineup custom-built for Alvey...

Continue Reading

Top 5 Most Recently Viewed Articles

MIRA Pharmaceuticals Unveils New Topical Treatment for Pain Relief

Updated Category News Views 386

MIRA Pharmaceuticals Takes a Bold Step in Pain Management On a notable day, MIRA Pharmaceuticals Inc. (NASDAQ: MIRA) announced an exciting development in their pipeline: the formulation of Ketamir-2 as a topical treatment aimed at delivering targeted relief from localized pain, particularly neuropathic and inflammatory pain. Expanding the Pain Management Portfolio This...

Continue Reading
XRP Tundra Launches Presale for Dual-Token System

Updated Category News Views 251

XRP Tundra Launches Presale for Dual-Token System XRP Tundra has officially kicked off phase two of its presale, offering the TUNDRA-S token at a stable price of $0.028. In addition to this, participants will receive complimentary allocations of the TUNDRA-X token. The team behind XRP Tundra envisions an ambitious launch price for TUNDRA-S at $2.50 and TUNDRA-X at $1.25,...

Continue Reading
Economic Insights: Government Shutdowns, Gold Trends, and AI Impact

Updated Category News Views 335

Government Shutdown's Influence on the Economy The potential for a government shutdown has sparked much debate regarding its impact on stock market performance. Historical trends show that the stock market might not react negatively to such events as previously thought. For instance, during the last eleven occurrences of government shutdowns, the S&P 500, tracked by the...

Continue Reading
Understanding the Daily Net Asset Values of WisdomTree ETFs

Updated Category News Views 184

Daily Net Asset Values of WisdomTree ETFs Investors often seek insights into the net asset values (NAVs) of exchange-traded funds (ETFs) to make informed decisions. Understanding how these values are calculated can give investors a clearer picture of the investment's potential. WisdomTree offers a diverse range of ETFs, each uniquely engineered to provide exposure to...

Continue Reading
Your Rights as an Investor in Zenas BioPharma and Next Steps

Updated Category News Views 182

Understanding the Class Action Lawsuit against Zenas BioPharma Zenas BioPharma, Inc. (NASDAQ: ZBIO) is currently facing a class action lawsuit aimed at protecting the interests of its investors. This legal action arises from allegations of securities fraud that impacted shareholders who bought into Zenas during its initial public offering. It is vital for those affected...

Continue Reading